Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Jain

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 14, 2024
Endometrial Cancer Treatment: Long-Term Engagement StrategiesKrisha J Howell, Angela Jain
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Rare epithelial tumors arising in or near the ovary: a review of the risk factors, presentation, and future treatment direction for ovarian clear cell and mucinous carcinomaAngela Jain, Michael V Seiden
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2012
Metastatic mucinous ovarian cancer and treatment decisions based on histology and molecular markers rather than the primary locationAngela Jain, Paula D Ryan, Michael V Seiden
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 20, 2017
National Cancer Database Report of Lymphadenectomy Trends in Endometrial CancerJames Cripe, Elizabeth Handorf, Jennifer Brown, et al.
Annals of Surgical Oncology|July 8, 2026
Role of Sentinel Node Surgery in Identifying Candidates for Adjuvant CDK4/6 Inhibitors: Implications of Choosing Wisely and ASCO Omission CriteriaAustin D Williams, Walker Lyons, Lindsey B Taylor, et al.
Science Signaling|February 20, 2020
Functional proteomics interrogation of the kinome identifies MRCKA as a therapeutic target in high-grade serous ovarian carcinomaAlison M Kurimchak, Carlos Herrera-Montávez, Jennifer Brown, et al.
British Journal of Clinical Pharmacology|November 9, 2024
Population pharmacokinetics and exposure-response relationships of dostarlimab in primary advanced or recurrent endometrial cancer in part 1 of RUBYMita Kuchimanchi, Trine Lembrecht Jørgensen, Eva Hanze, et al.
Nature Communications|July 27, 2023
A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumorsMatthew Zibelman, Alexander W MacFarlane, Kimberly Costello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2020
Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86)Neesha C Dhani, Hal W Hirte, Lisa Wang, et al.
JCO Precision Oncology|April 22, 2026
Temsirolimus in Patients With Solid Tumors With <i>PIK3CA</i> Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyEvan Pisick, Michael Rothe, Elizabeth Garrett-Mayer, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
International Journal of Radiation Oncology, Biology, Physics|January 14, 2024
Endometrial Cancer Treatment: Long-Term Engagement StrategiesKrisha J Howell, Angela Jain
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Rare epithelial tumors arising in or near the ovary: a review of the risk factors, presentation, and future treatment direction for ovarian clear cell and mucinous carcinomaAngela Jain, Michael V Seiden
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2012
Metastatic mucinous ovarian cancer and treatment decisions based on histology and molecular markers rather than the primary locationAngela Jain, Paula D Ryan, Michael V Seiden
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 20, 2017
National Cancer Database Report of Lymphadenectomy Trends in Endometrial CancerJames Cripe, Elizabeth Handorf, Jennifer Brown, et al.
Annals of Surgical Oncology|July 8, 2026
Role of Sentinel Node Surgery in Identifying Candidates for Adjuvant CDK4/6 Inhibitors: Implications of Choosing Wisely and ASCO Omission CriteriaAustin D Williams, Walker Lyons, Lindsey B Taylor, et al.
Science Signaling|February 20, 2020
Functional proteomics interrogation of the kinome identifies MRCKA as a therapeutic target in high-grade serous ovarian carcinomaAlison M Kurimchak, Carlos Herrera-Montávez, Jennifer Brown, et al.
British Journal of Clinical Pharmacology|November 9, 2024
Population pharmacokinetics and exposure-response relationships of dostarlimab in primary advanced or recurrent endometrial cancer in part 1 of RUBYMita Kuchimanchi, Trine Lembrecht Jørgensen, Eva Hanze, et al.
Nature Communications|July 27, 2023
A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumorsMatthew Zibelman, Alexander W MacFarlane, Kimberly Costello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 30, 2020
Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86)Neesha C Dhani, Hal W Hirte, Lisa Wang, et al.
JCO Precision Oncology|April 22, 2026
Temsirolimus in Patients With Solid Tumors With <i>PIK3CA</i> Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyEvan Pisick, Michael Rothe, Elizabeth Garrett-Mayer, et al.
Pageof 2